Akoya (AKYA) Tops Q4 EPS by 5c; offers guidance

Akoya (NASDAQ: AKYA) reported Q4 EPS of ($0.22), $0.05 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $26.5 million versus the consensus estimate of $26.13 million.

GUIDANCE:

Akoya sees FY2024 revenue of $114-118 million, versus the consensus of $116 million.

For earnings history and earnings-related data on Akoya (AKYA) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
• Stardust Power (SDST) Tops Q2 EPS by 1c